Apoptotic mesenchymal stem cells drive myocardial repair by activating RUNX1-TK1-mediated pyrimidine metabolic reprogramming in macrophages
Mesenchymal stem cell (MSC) therapy is promising for acute myocardial infarction (AMI), yet low post-transplantation survival remains a major hurdle. Emerging evidence suggests that apoptotic MSCs (aMSCs) are not mere "treatment failures" but actively modulate immune responses. Based on our preliminary findings t...